72
Participants
Start Date
October 31, 2002
Primary Completion Date
September 30, 2009
Study Completion Date
September 30, 2011
Dalteparin sodium injection
Experimental group: dalteparin sodium 200units/kg subcutaneous on day one, followed by 10,000 units subcutaneous daily for six days plus placebo tablets taken orally three times daily for seven days. Control group: Ibuprofen 800mg orally three times daily for seven days plus placebo injection subcutaneous daily for seven days.
Department of Veterans Affairs Medical Center, Oklahoma City
University of Oklahoma Health Science Center, Oklahoma City
Collaborators (1)
Pfizer
INDUSTRY
University of Oklahoma
OTHER